Heterosubtypic immunity to influenza A virus infection requires a properly diversified antibody repertoire |
| |
| Authors: | Nguyen Huan H Zemlin Michael Ivanov Ivaylo I Andrasi Judit Zemlin Cosima Vu Huong L Schelonka Robert Schroeder Harry W Mestecky Jiri |
| |
| Affiliation: | Department of Microbiology, The University of Alabama at Birmingham, Birmingham, Alabama 35294-2170, USA. hhnguyen@ivi.int |
| |
| Abstract: | Heterosubtypic immunity (HSI) is defined as cross-protection to infection with an influenza A virus serotype other than the one used for primary infection. Although HSI has been thought to be mediated by serotype cross-reactive cytotoxic T lymphocytes (CTL) that recognize conserved epitopes of structural proteins, recent studies suggest that antibodies (Abs) may make a significant contribution. In this study, we provide further evidence for the role of Abs in HSI using transgenic mice lacking terminal deoxyribonucleotidyltransferase (TdT), which adds N nucleotides to V-D and D-J junctions of the complementary determining region 3 (CDR3) (TdT(-/-)) and mice with altered Ab repertoires due to replacement of the complete locus of heavy chain diversity segments (D(H)) with an altered D(H) segment (namely, Delta D-iD). Both types of mice failed to generate complete HSI, although they were able to mount protective immunity to a homologous challenge. Lower levels of virus-specific antibodies along with more severely impaired HSI were observed in TdT(-/-) mice compared to those in Delta D-iD mice, while CTL activity remained unchanged in both types of mice. These findings indicate that a properly diversified antibody repertoire is required for HSI and that N addition by TdT is a more effective mechanism in the induction of a properly diversified antibody repertoire and, therefore, complete HSI. The results suggest that the diversity of the antibody repertoire as determined by the composition of the D region of HCDR3 and by N addition are among the mechanisms selected for in evolution to create a favorable environment to resolve infections with mutated viruses. |
| |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ |
|
